The induction agent effect on BK viremia in renal and pancrease transplant patients.

Trial Profile

The induction agent effect on BK viremia in renal and pancrease transplant patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Sep 2011

At a glance

  • Drugs Antithymocyte globulin; Basiliximab; Corticosteroid; Corticosteroids; Mycophenolate sodium; Tacrolimus
  • Indications Pancreas transplant rejection; Renal transplant rejection
  • Focus Adverse reactions
  • Most Recent Events

    • 15 Sep 2011 Trial phase changed from II to IV as reported by ClinicalTrials.gov.
    • 15 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 21 Jan 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top